Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...

Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...

The President's Emergency Plan for AIDS Relief has been the subject of a series of presidential orders and memos that have ...

Human immunodeficiency virus (HIV) is a virus that attacks the body's immune system. HIV is a manageable chronic condition. With treatment, people living with HIV can have long and healthy lives.

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

GSK was able to offset the decline thanks to a better-than-expected performance for its cancer medicines and HIV therapeutics sold by majority-owned joint venture ViiV Healthcare, which helped group ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health and more research on other diseases.

HB-500 utilizes two genetically engineered replicating vectors based on arenaviruses to deliver HIV antigens, with the goal of inducing robust and durable immunity. The vaccine aims to cover more ...

The American pharmaceutical company Moderna is developing an mRNA-based vaccine candidate for norovirus, designated as mRNA-1403. This vaccine is designed to protect against multiple norovirus ...

As norovirus cases increase across the U.S., Moderna is conducting a phase 3 trial with 25,000 participants to test its experimental vaccine, CNBC reported. The vaccine manufacturer is recruiting ...